Type 1 diabetes is a chronic autoimmune condition affecting over 9 million people worldwide, caused by the body's immune system attacking the insulin-producing cells in the pancreas, resulting in high ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The first trial of semaglutide in patients with type 1 ...

Insulin-producing cells can be genetically modified to hide from the immune system. People with type 1 diabetes must constantly rely on insulin injections or pumps, usually for the rest of their life ...

Type 2 diabetes, linked to insulin resistance, affects a significant portion of the American population, many undiagnosed. Pre-diabetes, also caused by insulin resistance, often progresses to Type 2 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. State-level out-of-pocket insulin caps did not boost ...

A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin needs but leaves tissue-level insulin resistance unchanged. Study: Effect of metformin on insulin ...